Pfizer aims for full FDA approval of vaccine
Pfizer and German partner BioNTech have a shot at winning the first full approval from the U.S. Food and Drug Administration.
Pfizer and German partner BioNTech have a shot at winning the first full approval from the U.S. Food and Drug Administration.